Market revenue in 2023 | USD 328.6 million |
Market revenue in 2030 | USD 606.7 million |
Growth rate | 9.2% (CAGR from 2023 to 2030) |
Largest segment | Anti-infective |
Fastest growing segment | Chemotherapy |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 24.38% in 2023. Horizon Databook has segmented the Netherlands home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
According to National Institute for Public Health and the Environment, nearly 1 in every 5 people in the Netherlands will have more than three chronic diseases by 2040. Moreover, by 2040, mental disorders, cardiovascular diseases, and cancer are expected to be the most commonly diagnosed disease groups, whereas arthrosis, neck & back pain, and diabetes are expected to rapidly increase during the next few years.
Growing prevalence of these diseases is anticipated to fuel market growth in the country. According to the study published in the PLOS ONE, it has been estimated that administration of home treatment in the country costs around USD 133 per hour , whereas the per day cost of inpatient care of a physically disabled person is about USD 228 , which acts as a costeffective alternative for chronic care patients.
Furthermore, home care costs are shared by municipalities, insurers, & the national government and is financed via the Health Insurance Act. In addition, hospice care is covered under the Long-term Care Act. The inclusion of home care in publicly financed patient care is anticipated to reduce the financial burden on patients and significantly increase the adoption of home infusion therapies in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Netherlands home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into Netherlands home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account